Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Companyâ€™s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

05/11 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
25/26/25	SEK 0.2010	+2.55%	4,18,855
24/26/24	SEK 0.1960	-3.21%	11,29,894
23/26/23	SEK 0.2025	0.00%	3,51,032
22/26/22	SEK 0.2025	+0.25%	2,47,681
21/26/21	SEK 0.2020	-3.35%	4,75,109

Delayed Quote Nasdaq Stockholm

More quotes

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Stockholm 09:30:00 25/09/2026 pm IST			5-day change	1st Jan Change
0.2010 ^SEK	+2.55%		-5.19%	-25.00%

17/09	Nine stocks have so far today hit new 52-week lows on the Stockholm stock exchange	FW
11/09	Acarix Publishes Peer-Reviewed Study Confirming CADScor System Diagnoses Heart Failure With Fewer False Positives Than Standard Blood Test	CI

Market Cap	25Cr 2.51Cr 2.21Cr 2.08Cr 1.9Cr 3.55Cr 240.97Cr 3.58Cr 9.66Cr 123.11Cr 9.44Cr 9.24Cr 395.65Cr	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	25Cr 2.51Cr 2.21Cr 2.08Cr 1.9Cr 3.55Cr 240.97Cr 3.58Cr 9.66Cr 123.11Cr 9.44Cr 9.24Cr 395.65Cr	EV / Sales 2026 *	17.8x	EV / Sales 2027 *	7.79x
Free-Float	89.13%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Nasdaq Stockholm	ACARIX	Delayed
OTC Markets	ACIXF	Delayed
Deutsche Boerse AG	7AC	Delayed
CBOE		Real-time
CBOE		Real-time

17/09	Nine stocks have so far today hit new 52-week lows on the Stockholm stock exchange	FW
11/09	Acarix Publishes Peer-Reviewed Study Confirming CADScor System Diagnoses Heart Failure With Fewer False Positives Than Standard Blood Test	CI
14/08	Acarix AB, Q2 2026 Earnings Call, Aug 13, 2026
13/08	Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
13/08	Calendar for Thursday, August 13	FW
10/08	Acarix Receives Regulatory Approval For The CADScor System In The UAE	CI
10/08	Acarix Receives UAE Clearance for Point-of-Care Diagnostic Aid	MT
18/06	Acarix AB Announces Directorate Appointments	CI
16/06	Acarix AB Announces That Marlou Janssen-Counott Declines Re-Election as A Member of the Board of Directors	CI
12/06	Calendar Monday June 15 - Friday June 19	FW
21/05	Acarix AB, Q1 2026 Earnings Call, May 18, 2026
18/05	Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
07/05	Calendar: Thursday, May 7	FW

Acarix AB Share Price

Stocks

ACARIX

SE0009268717

Advanced Medical Equipment & Technology

Valuation: Acarix AB

Chart: Acarix AB

Latest news: Acarix AB

Last Transcript: Acarix AB

Analysts' recommendations: Acarix AB

Press Releases: Acarix AB

Quotes and Performance

Price Extremes

Managers and Directors: Acarix AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

14/09	Acarix: Seismocardiography gains further validation in heart failure	AQ
11/09	Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test	AQ
17/08	Acarix (Q2 Review): Laying the groundwork	AQ
13/08	Acarix (Q2 Initial take): In line with estimates	AQ
13/08	Acarix Publishes Second Quarter and First Half 2026 Results	AQ

1 day	+2.55%
1 week	-5.19%
Current month	-18.29%
1 month	-13.73%
3 months	-24.86%
6 months	-29.35%
Current year	-25.00%

1 week	0.2	0.21
1 month	0.2	0.25
Current year	0.2	0.33
1 year	0.2	0.35
3 years	0.17	0.6
5 years	0.17	1.47
10 years	0.17	26.8

Manager	Title	Age	Since
Aamir Mahmood CEO	Chief Executive Officer	-	01/02/2024
Christian Lindholm CEO	Chief Executive Officer	62	23/02/2018

Director	Title	Age	Since
Louise Janssen-Counotte BRD	Director/Board Member	61	01/01/2020
Kenneth Nelson BRD	Director/Board Member	52	14/05/2024
Tony Das BRD	Director/Board Member	-	14/05/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACARIX AB	+2.55%	-5.19%	-31.28%	-16.25%	2.44Cr
SARTORIUS AG	-2.64%	+4.03%	+27.37%	-18.75%	1.87TCr
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-5.20%	-1.26%	-40.28%	+23.38%	184.81Cr
ECKERT & ZIEGLER SE	0.00%	-0.49%	-32.73%	+22.85%	87Cr
VAREX IMAGING CORPORATION	-0.11%	-0.49%	+50.49%	-2.02%	78Cr
QUIDELORTHO CORPORATION	+2.34%	-1.35%	-59.01%	-84.73%	73Cr
CONTEC MEDICAL SYSTEMS CO.,LTD	-0.69%	+8.32%	-30.46%	-46.60%	69Cr
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+1.77%	+5.45%	-38.77%	-51.24%	59Cr
908 DEVICES INC.	-0.69%	+4.19%	+51.32%	+89.40%	48Cr
CELLAVISION AB	+5.05%	+5.94%	-0.46%	+5.94%	40Cr
Average	+0.36%	+1.24%	-10.38%	-7.80%	250.51Cr
Weighted average by Cap.	-1.96%	+5.28%	+15.31%	-14.69%

	2026 *	2027 *
Net sales	1.4Cr 14.12L 12.39L 11.7L 10.66L 19.96L 14Cr 20.1L 54.22L 6.91Cr 53L 51.86L 22Cr	3.2Cr 32.27L 28.31L 26.74L 24.37L 45.62L 31Cr 45.94L 1.24Cr 16Cr 1.21Cr 1.19Cr 51Cr
Net income	-3.08Cr -31.06L -27.25L -25.74L -23.46L -43.91L -30Cr -44.22L -1.19Cr -15Cr -1.17Cr -1.14Cr -49Cr	-1.53Cr -15.43L -13.54L -12.79L -11.65L -21.81L -15Cr -21.97L -59.26L -7.55Cr -57.92L -56.67L -24Cr
Net Debt	-	-